Stay updated with breaking news from Medicine inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bollard Group LLC acquired a new position in shares of Prime Medicine, Inc. (NYSE:PRME – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 361,136 shares of the company’s stock, valued at approximately $3,200,000. Bollard Group LLC owned approximately 0.37% of Prime […] ....
MDMA Drug for PTSD Fails to Get Backing From FDA Advisers bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) and Clearmind Medicine (NASDAQ:CMND – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk. Profitability This table compares Esperion Therapeutics and […] ....
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […] ....
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) and Clearmind Medicine (NASDAQ:CMND – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings. Analyst Ratings This is a summary of […] ....